October 18, 2016
Embrace Pharmacogenomics in Your Practice
By Sharon Rosen
Article by Rachel Guibert, Public Affairs Currently, a population with a given disease generally receives the same therapy for all patients. Pharmacogenomics will change this ‘one-size-fits-all’ approach to drug treatments. Konstantinos Lazaridis, M.D., Eric Matey, Pharm.D., R.Ph., and Jeffrey Bishop, Pharm.D., M.S., B.C.P.P., are expecting a future practice reality in which clinicians will have every […]
Tags: #Dr. Jeffrey Bishop, #drug-gene reactions, #preemptive pharmacogenomics, center for individualized medicine, Dr. Eric Matey, Dr. Konstantinos Lazaridis, mayo clinic, PGx, pharmacogenomics